PubMed:24373830 / 1662-1964 JSONTXT

{"project":"PubMed_Structured_Abstracts","denotations":[{"id":"T5","span":{"begin":0,"end":302},"obj":"CONCLUSIONS"}],"text":"Use of COS PIVCs reduced episodes of phlebitis and risk of infection at a cost of only € 0.09/day. When PIVCs are replaced based on clinical indication, COS PIVCs last for up to 144 h and MOS PIVCs last for up to 96 h without increased risk and with significant cost savings (€ 786,257/year/1000 beds)."}